A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)

NCT03488030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2022-02-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the percentage of moderate to severe IBD participants with active disease at Day 1.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03488030 on ClinicalTrials.gov